Jason Blum Hosting Special 'Paranormal Activity' Performance On Broadway Next Week
Deadline
β’Fri, 21 Aug 2026 18:28:23 +0000
π° What Happened
Jason Blum, founder of Blumhouse, will host a special performance of the play Paranormal Activity on Wednesday, August 26, at the August Wilson Theatre on Broadway. Blum is a producer on the show, which opens the night before after a preview run that began last week. The play, written by Levi Holloway and directed by Felix Barrett, adapts the found-footage film franchise that has generated more than $900 million globally, while Blumhouse Atomic Monster and Paramount are also producing an eighth film installment due in theaters early next summer.
π The Backstory
Paranormal Activity began as an inexpensive found-footage horror movie that became one of the most profitable film franchises ever. The stage version reimagines the ghost story for live theatre, part of a trend of turning horror IP into immersive stage experiences.
π― Why It Matters
The stage adaptation extends a massively successful horror franchise into live theatre, testing whether horror works as a Broadway draw. It also highlights Blumhouse's expansion of its horror brand beyond film.
Jason Blum, founder of Blumhouse, will host a special performance of the play Paranormal Activity on Wednesday, August 26, at the August Wilson Theatre on Broadway. Blum is a producer on the show, which opens the night before after a preview run that began last week. The play, written by Levi Holloway and directed by Felix Barrett, adapts the found-footage film franchise that has generated more than $900 million globally, while Blumhouse Atomic Monster and Paramount are also producing an eighth film installment due in theaters early next summer.
Paranormal Activity began as an inexpensive found-footage horror movie that became one of the most profitable film franchises ever. The stage version reimagines the ghost story for live theatre, part of a trend of turning horror IP into immersive stage experiences.
The stage adaptation extends a massively successful horror franchise into live theatre, testing whether horror works as a Broadway draw. It also highlights Blumhouse's expansion of its horror brand beyond film.